This preview shows
page 1. Sign up
to
IPPH 362
Test 3 Key
10/25/06
1.
true
17A. 5400 mL
2.
false
17B. 6.4 Liters/min
3.
false
18. sodium dihydrogen phosphate-acid
4.
true
disodium hydrogen phosphate-salt
5A. 2
19A. 5.0-5.2
5B. 1
19B. minimize buffer capacity
5C. 7
minimize volume administered
6A. 4
administer slowly
6B. 2
20. 8
6C. 3
3
7A. 2 or 5
6
7B. 3
10
7C. 4
3
7D. 5
9
8A. 2
21A. 30 days
8B. 4
21B. 9.5 months
8C. 1
This is the end of the preview.
Sign up
to
access the rest of the document.
Unformatted text preview: 21C. 0.00014/day 9A. 1 22. 0.17 9B. 2 23. 0.03 10. 1 11. nitroglycerin 12. digoxin theophylline phenytoin(Dilantin) carbamazepine(Tegretol) 5-fluorouracil 13. exclude oxygen trace metals light include antioxidant chelating agent buffer 14. aspirin displaces wafarin from plasma proteins 15. hepatic first pass effect with portal vein 16. saturation of hepatic enzymes...
View
Full Document
- Spring '08
- HEM
- Hepatic portal system, chelating agent buffer, digoxin theophylline phenytoin, true disodium hydrogen
-
Click to edit the document details
